Thursday, May 18, 2017

BRIEF-Veracyte says Anthem coverage for the Afirma gene expression classifier for use in thyroid cancer diagnosis

* Veracyte announces Anthem coverage for the Afirma® gene expression classifier for use in thyroid cancer diagnosis

by reutersCOMPANYNEWS via Endless Supplies .Biz - News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)